Sort
15,842 grants matching “pancreatic cancer”
Systemic Inhibition of Monocyte Chemoattractant Protein-1 (MCP-1; CCL2)
$266,856Robert Loberg · University Of Michigan At Ann Arbor · P50 · FY2011 · CA
CA: GASTROINTESTINAL (GI) TISSUE RESOURCE
$266,855Achyut Bhattacharyya · University Of Arizona · P50 · FY2011 · CA
Mechanistic and Translational Studies of PR-104:A New Hypoxia Activated Cytotoxin
$266,819John Martin Brown · Stanford University · P01 · FY2007 · CA
Core B: Biospecimen Core
$266,752Ryan C Fields · Washington University · P50 · FY2025 · CA
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
$266,723Amato J. Giaccia · Stanford University · P01 · FY2007 · CA
Biospecimen Acquisition, Processing, and Classification Unit
$266,600Ryan C Fields · Washington University · U2C · FY2020 · CA
Core B â Human Biospecimen and Advanced Sequencing Core
$266,598Leonidas G Koniaris · Medical University Of South Carolina · P01 · FY2021 · CA
PDX-1 is a Therapeutic Target for Pancreatic Cancer
$266,570Francis Charles Brunicardi · Baylor College Of Medicine · R01 · FY2011 · CA
Activating liver carcinogens in yeast by expressing CYP450 polymorphisms
$266,250Michael Thomas Fasullo · Ordway Research Institute, Inc. · R21 · FY2007 · ES
Integrated Small Animal Imaging Research Resource
$266,243Chin-Tu Chen · University Of Chicago · P30 · FY2018 · CA
Detection and Diagnosis of Pancreatic Cancer
$266,228Ctr For Molecular Medicine/Immunology · R01 · FY2005 · CA
Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells
$266,186Carl H. June · University Of Pennsylvania · R01 · FY2008 · CA
Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells
$266,186Carl H. June · University Of Pennsylvania · R01 · FY2009 · CA
Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells
$266,186Carl H. June · University Of Pennsylvania · R01 · FY2010 · CA
Pharmacologic /Genetic Inhibition of XBP1 as Hypoxia Targeted Therapeutic Strateg
$266,097Albert Koong · Stanford University · P01 · FY2010 · CA
Peripheral blood biopsy for molecular diagnosis of pancreatic cancer
$266,061Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R21 · FY2012 · CA
The Fulvene Approach to the Syntheses of Antitumor Agents
$265,939Ihsan Erden · San Francisco State University · SC1 · FY2012 · GM
The Fulvene Approach to the Syntheses of Antitumor Agents
$265,939Ihsan Erden · San Francisco State University · SC1 · FY2011 · GM
Pancreatic Cancer Prevention with NO-releasing NSAIDs
$265,900State University New York Stony Brook · R01 · FY2004 · CA
Pancreatic Fluid Proteomics in Alcohol Induced Chronic Pancreatitis
$265,878Darwin Lewis Conwell · Brigham And Women'S Hospital · R21 · FY2010 · DK
Development of molecular probes for biomedical applications
$265,770Weihong Tan · University Of Florida · R01 · FY2007 · GM
Animal Core
$265,748Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2014 · CA
Cytoskeletal Dynamics in Pancreatic Cancer Metastasis
$265,742Mark A. Mc Niven · Mayo Clinic Rochester · R01 · FY2006 · CA
Enhanced Chemosensitivity of Pancreatic Cancer
$265,742M Guillaume Wientjes · Ohio State University · R01 · FY2006 · CA
Biospecimen Acquisition, Processing, and Classification Unit
$265,733Ryan C Fields · Washington University · U2C · FY2022 · CA